The Phase 3 trial results for VQW-765 failed to confirm findings from an earlier mid-stage trial of VQW-765 that had suggested the drug could reduce social anxiety symptoms

552c7ae14

Mental health

Supports emotional wellbeing and psychological resilience through digital tools or professional care access.

3 debates·795 claims·43 news stories

0